Status:
COMPLETED
Robotic Walking Device to Improve Mobility in Parkinson's Disease
Lead Sponsor:
Ohio State University
Collaborating Sponsors:
Michael J. Fox Foundation for Parkinson's Research
Honda Research and Development Americas
Conditions:
Parkinson Disease
Eligibility:
All Genders
50-80 years
Phase:
NA
Brief Summary
This Phase II randomized controlled trial proposes to examine the impact of long-term use of a novel light-weight and wearable assistive robotic device, called the Honda Walking Assist (HWA) device, t...
Detailed Description
Difficulties with walking in people with Parkinson's disease contribute to injurious falls and decreased quality of life. The Honda Walking Assist (HWA) robotic device is designed to assist individual...
Eligibility Criteria
Inclusion
- Diagnosis of idiopathic Parkinson's disease
- Age 50-80 years
- Able to ambulate without assistance (Hoehn \& Yahr stages 1-3)
- On stable doses of Parkinson's medications for at least 4 weeks prior to the study.
Exclusion
- Presence of other significant cardiac, neurological or orthopedic problems that affect gait
- Weight more than 220 pounds and height greater than 6'8"
- Electronic medical devices embedded in the body
- Participating in any physical therapy
- Inability to understand instructions required by the study.
Key Trial Info
Start Date :
May 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 27 2021
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT03751371
Start Date
May 15 2019
End Date
September 27 2021
Last Update
June 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ohio State University
Columbus, Ohio, United States, 43210